Drug–Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients
Open Access
- 1 March 2021
- journal article
- research article
- Published by Springer Nature in Drugs & Aging
- Vol. 38 (4) , 341-346
Abstract
Background Patients with coronavirus disease 2019 (COVID-19) are often elderly, with comorbidities, and receiving polypharmacy, all of which are known factors for potentially severe drug–drug interactions (DDIs) and the prescription of potentially inappropriate medications (PIMs). Objective The aim of this study was to assess the risk of DDIs and PIMs in COVID-19 patients at hospital discharge. Method Patients with a proven diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who were hospitalized between 21 February and 30 April 2020, treated with at least two drugs, and with available information regarding pharmacological treatments upon admission and at discharge were considered. The appropriateness of drug prescriptions was assessed using INTERcheck®. Results A significant increase in the prescription of proton pump inhibitors and heparins was found when comparing admission with hospital discharge (from 24 to 33% [p < 0.05] and from 1 to 17% [p < 0.01], respectively). The increased prescription of heparins at discharge resulted in a highly significant increase in the potentially severe DDIs mediated by this class of drugs. 51% of COVID-19 patients aged > 65 years had at least one PIM upon admission, with an insignificant increment at discharge (58%). Conclusion An increased number of prescribed drugs was observed in COVID-19 patients discharged from our hospital. The addition of heparins is appropriate according to the current literature, while the use of proton pump inhibitors is more controversial. Particular attention should be paid to the risk of bleeding complications linked to heparin-based DDIs.Keywords
Funding Information
- Università degli Studi di Milano
This publication has 23 references indexed in Scilit:
- Potential drug-drug interactions in ICU patients: a retrospective studyDrug Metabolism and Drug Interactions, 2020
- Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19Diabetes, 2020
- Risk factors associated with disease severity and length of hospital stay in COVID-19 patientsJournal of Infection, 2020
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, ChinaJAMA Internal Medicine, 2020
- Major Neurologic Adverse Drug Reactions, Potential Drug–Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative ReviewTherapeutics and Clinical Risk Management, 2020
- Using heparin molecules to manage COVID‐2019Research and Practice in Thrombosis and Haemostasis, 2020
- Proton Pump InhibitorsGastrointestinal Endoscopy Clinics of North America, 2020
- Reducing Potentially Inappropriate Prescriptions for Older Patients Using Computerized Decision Support Tools: Systematic ReviewJournal of Medical Internet Research, 2019
- A Case‐Crossover–Based Screening Approach to Identifying Clinically Relevant Drug–Drug Interactions in Electronic Healthcare DataClinical Pharmacology & Therapeutics, 2019
- Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic reviewBMC Geriatrics, 2015